Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

pharma_clinical_successUnited StatesCNBC4h ago

Context

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90% CNBC Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STAT Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano Business Wire World in Brief: trials show promise for a skin-cancer vaccine; Trump pauses Canada tariffs The Economist Cancer treatment could face landmark moment with promising vaccine The Washington Post

What it means

Causal chain

No clear market signal

How to read a signal

Severity: the event's market impact, 1–5
Direction: ↑ / ↓ likely price move for the asset
Exp. move: the size of the abnormal move we'd expect if the call plays out — not a claim a move will happen:
Ssmall<1%
Mmoderate1–5%
Llarge>5%
Most flagged events don't move beyond noise; those count against us (see the track record).
Timeframe: the window we measure over:
1dshort
5dmedium
21dlong
Conviction: how well-established the directional call is (textbook → speculative) — not a guaranteed outcome:
low
average
strong

Read the original source ↗

Get the next signal the moment it breaks.

The full live feed, asset filters, and alerts — free.

Not investment advice · for informational purposes only. Generated 1h ago